Surgery Websites
Sarwal Lab »  Collaborators »  UCSF Collaborators »  Qizhi Tang, Ph.D.
Qizhi Tang, Ph.D.

Qizhi Tang, Ph.D.

Professor of Surgery
Division of Transplant Surgery
Director, Transplantation Research Laboratory

Contact Information

(415) 476-1739
(415) 476-0789
(415) 502-8326 Fax

Open Popup
  • Peking Union Medical College, China, toward MD, 1984-89
  • University of South Alabama, toward PhD, Microbiology, 1989-91
  • University of Illinois at Chicago, Ph.D., Immunology, 1991-96
  • University of Illinois, Chicago, Postdoctoral Fellow, Immunology, 1996-98
  • University Of Chicago, Postdoctoral Fellow, Immunology, 1998-00
  • University of California, San Francisco, California, Postdoctoral Fellow, Immunology, 2000-02
  • Autoimmunity
  • Immune Tolerance
  • Immunotherapy
  • Islets of Langerhans Transplantation
  • Suppressor-Effector
  • T-Lymphocyte Subsets
  • T-Lymphocytes
  • Transplantation Immunology
  • Transplantation Tolerance

Dr. Tang attended Peking Union Medical College in China. After completing 5 years of the 8-year MD training, she left the program to pursue graduate education in the US and received her PhD in immunology from the University of Illinois at Chicago. She completed postdoctoral fellowships investigating mechanisms of immune tolerance at the University of Chicago and the University of California, San Francisco.

Dr. Tang joined the faculty at the University of California, San Francisco in 2002 as an Assistant Professor of Pathology in the Diabetes Center where she researched mechanisms of immune tolerance. She joined the Transplantation Division in the Department of Surgery in 2007 to lead basic research and translational research in transplant immunology. She has been the director of the UCSF Transplantation Research Laboratory since 2007 where she leads basic and translational research in transplantation.

A major research focus in the Tang Lab is on regulatory T cell therapy for autoimmune diseases and transplantation. Since 2011, she has also been co-directing the regulatory T cell therapy program at UCSF, which has supported 10 early-phase clinical trials in type 1 diabetes, pemphigus, islet transplantation, kidney transplantation and liver transplantation. Another area of research in the Tang Lab is on optimizing islet transplantation to enable highly efficient immunosuppression-free replacement of pancreatic beta cells for the treatment of type 1 diabetes.

Publications provided by UCSF Profiles, powered by CTSI.
  1. Ferreira LMR, Muller YD, Bluestone JA, Tang Q. Next-generation regulatory T cell therapy. Nat Rev Drug Discov. 2019 10; 18(10):749-769. View in PubMed
  2. Chendke GS, Faleo G, Juang C, Parent AV, Bernards DA, Hebrok M, Tang Q, Desai TA. Supporting Survival of Transplanted Stem-Cell-Derived Insulin-Producing Cells in an Encapsulation Device Augmented with Controlled Release of Amino Acids. Adv Biosyst. 2019 Sep; 3(9). View in PubMed
  3. Azimi CS, Tang Q, Roybal KT, Bluestone JA. NextGen cell-based immunotherapies in cancer and other immune disorders. Curr Opin Immunol. 2019 08; 59:79-87. View in PubMed
  4. Savage TM, Shonts BA, Obradovic A, Dewolf S, Lau S, Zuber J, Simpson MT, Berglund E, Fu J, Yang S, Ho SH, Tang Q, Turka LA, Shen Y, Sykes M. Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight. 2018 11 15; 3(22). View in PubMed
  5. Desai TA, Tang Q. Islet encapsulation therapy - racing towards the finish line? Nat Rev Endocrinol. 2018 11; 14(11):630-632. View in PubMed
  6. View All Publications


Site Directory